ATE206421T1 - Heterocyclisch substituierte piperazonderivate als tachykinin rezeptor antagonisten - Google Patents

Heterocyclisch substituierte piperazonderivate als tachykinin rezeptor antagonisten

Info

Publication number
ATE206421T1
ATE206421T1 AT96905333T AT96905333T ATE206421T1 AT E206421 T1 ATE206421 T1 AT E206421T1 AT 96905333 T AT96905333 T AT 96905333T AT 96905333 T AT96905333 T AT 96905333T AT E206421 T1 ATE206421 T1 AT E206421T1
Authority
AT
Austria
Prior art keywords
piperazone
derivatives
receptor antagonists
heterocyclic substituted
tachykinin receptor
Prior art date
Application number
AT96905333T
Other languages
English (en)
Inventor
Timothy P Burkholder
Elizabeth M Kudlacz
Tieu-Binh Le
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of ATE206421T1 publication Critical patent/ATE206421T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
AT96905333T 1995-03-15 1996-02-06 Heterocyclisch substituierte piperazonderivate als tachykinin rezeptor antagonisten ATE206421T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40478895A 1995-03-15 1995-03-15
PCT/US1996/001437 WO1996028441A1 (en) 1995-03-15 1996-02-06 Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists

Publications (1)

Publication Number Publication Date
ATE206421T1 true ATE206421T1 (de) 2001-10-15

Family

ID=23601038

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96905333T ATE206421T1 (de) 1995-03-15 1996-02-06 Heterocyclisch substituierte piperazonderivate als tachykinin rezeptor antagonisten

Country Status (21)

Country Link
US (2) US5840726A (de)
EP (1) EP0815105B1 (de)
JP (1) JP3825472B2 (de)
KR (1) KR19980703032A (de)
CN (1) CN1067068C (de)
AR (1) AR002715A1 (de)
AT (1) ATE206421T1 (de)
AU (1) AU697599B2 (de)
CA (1) CA2215333C (de)
DE (1) DE69615670T2 (de)
DK (1) DK0815105T3 (de)
ES (1) ES2164235T3 (de)
FI (1) FI973671A0 (de)
HU (1) HUP9702149A3 (de)
IL (1) IL117453A (de)
NO (1) NO314693B1 (de)
NZ (1) NZ302948A (de)
PT (1) PT815105E (de)
TW (1) TW464647B (de)
WO (1) WO1996028441A1 (de)
ZA (1) ZA961954B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000502100A (ja) * 1995-12-18 2000-02-22 藤沢薬品工業株式会社 タキキニン拮抗薬としてのピペラジン誘導体
DE19939910A1 (de) * 1999-08-23 2001-03-01 Morphochem Ag Neue Verbindungen, die Tryptase-Aktivität hemmen
CN101404986B (zh) * 2002-05-17 2011-09-28 赛奎拉公司 用于诊断和治疗感染性疾病的组合物和制药方法
US7456222B2 (en) * 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
EP1670314A4 (de) * 2003-09-05 2009-02-25 Sequella Inc Verfahren und zusammensetzungen enthaltend diamine als neue therapeutika für tuberkulose
US20090281054A1 (en) * 2008-05-06 2009-11-12 Venkata Reddy Compositions and methods comprising capuramycin analogues

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3132882A1 (de) * 1981-08-20 1983-03-03 Cassella Ag, 6000 Frankfurt Neue piperazinone, ihre herstellung und verwendung
FI97540C (fi) * 1989-11-06 1997-01-10 Sanofi Sa Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical compositions containing them
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
WO1994003483A1 (en) * 1992-07-30 1994-02-17 Chiron Corporation Endothelin receptor-binding compounds
GB9222486D0 (en) * 1992-10-26 1992-12-09 Merck Sharp & Dohme Therapeutic agents
WO1994026735A1 (en) * 1993-05-06 1994-11-24 Merrell Dow Pharmaceuticals Inc. Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
ES2164235T3 (es) 2002-02-16
CN1178529A (zh) 1998-04-08
CA2215333C (en) 2002-01-01
CN1067068C (zh) 2001-06-13
US5864045A (en) 1999-01-26
PT815105E (pt) 2002-03-28
AU697599B2 (en) 1998-10-08
AU4930696A (en) 1996-10-02
CA2215333A1 (en) 1996-09-19
TW464647B (en) 2001-11-21
EP0815105A1 (de) 1998-01-07
NZ302948A (en) 2001-05-25
WO1996028441A1 (en) 1996-09-19
NO974205D0 (no) 1997-09-12
DK0815105T3 (da) 2002-01-21
DE69615670T2 (de) 2002-08-08
HUP9702149A2 (hu) 1999-06-28
KR19980703032A (ko) 1998-09-05
FI973671L (fi) 1997-09-12
AR002715A1 (es) 1998-04-29
NO974205L (no) 1997-11-13
MX9706872A (es) 1997-11-29
FI973671A7 (fi) 1997-09-12
EP0815105B1 (de) 2001-10-04
IL117453A (en) 2000-07-26
DE69615670D1 (de) 2001-11-08
JP3825472B2 (ja) 2006-09-27
JPH11501917A (ja) 1999-02-16
NO314693B1 (no) 2003-05-05
ZA961954B (en) 1996-09-17
IL117453A0 (en) 1996-07-23
FI973671A0 (fi) 1997-09-12
US5840726A (en) 1998-11-24
HUP9702149A3 (en) 1999-07-28

Similar Documents

Publication Publication Date Title
DE69531458D1 (de) Chinolinderivate als tachykinin nk3 rezeptor antagonisten
FI970107A7 (fi) Heterosyklisiä takykiniinireseptoriantagonisteja
DE69728392D1 (de) Indolderivate verwendbar als endothelinrezeptorantagonisten
ATE197300T1 (de) Indolderivate als 5-ht rezeptorantagoniste
NO951613D0 (no) Ikke-peptidyl tachykinin reseptorantagonister
ATE222892T1 (de) Pyrimidinderivate als 5ht2c-rezeptorantagonisten
DE69714265D1 (de) Tetrahydrochinolinderivate als eaa antagonisten
ATE400554T1 (de) 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives als muskarin-rezeptor antagonisten
DE69418045D1 (de) Amidderivate als 5ht1d rezeptor antagonisten
DE69626220D1 (de) 3-azetidinylalkylpiperidine oder -pyrrolidine als tachykinin antagonisten
FI973283L (fi) 5-(4-substituoitu piperidinyyli-1)-3-aryyli-valeriaanahappojohdannaisia takykiniinireseptoriantagonisteina
ATE286022T1 (de) Naphthalin-carboxamide als tachykinin rezeptorantagonisten
ATE240954T1 (de) Oxazolidinone als 5-ht2a-antagonisten
DE69703242D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
ID24468A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin
ATE325118T1 (de) Piperazinoderivate als neurokinin-antagonisten
DE69615670D1 (de) Heterocyclisch substituierte piperazonderivate als tachykinin rezeptor antagonisten
DE69717449D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
DE69617010D1 (de) Isazole derivate als fibrinogen-rezeptor-antagonisten
ID24309A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin
FI941118A7 (fi) Bentsyyli-imidatsopyridiinijohdannainen angiotensiini II reseptoriantagonistina
ATE286882T1 (de) Carboxy substituierte carboxamidderivative als tachykinin rezeptorantagoniste
DK0940391T3 (da) Quinolinderivater som tachykinin-NK3-receptor-antagonister
FI941117A0 (fi) Bentsyyli-imidatsopyridiinijohdannaiset angiotensiini II reseptoriantagonisteina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee